Oasmia presents Paclical® Vet in Budapest
The pharmaceutical company Oasmia Pharmaceutical will present results from a phase I/II study with the cancer product Paclical® Vet at the Veterinary European ECVIM-CA Congress 13-15 September in Budapest. The results have been presented earlier and have reached great international interest.
The press release is available in PDF-format here.

